Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eimOCrsecrAJmRqFhRTM

January 25, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  • Discount cards and coupons mask sky-high drug costs
    Prices on brand-name drugs were up more than 13% in September over the previous year, and drugmakers are increasingly developing treatments for rare diseases and pricing those drugs at hundreds of thousands of dollars per patient per year. Drugmakers increasingly offer discount cards and copay coupons to help patients afford expensive brand-name drugs, but commercial insurers bear the brunt of the costs -- a cycle that keeps health care spending high. The nation will pay an extra $32 billion on prescription drugs over the next 10 years unless the use of discount cards and coupons is halted, a PCMA study found. LearnVest (1/18) LinkedInFacebookTwitterEmail this Story
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • FDA considers reclassification of hydrocodone-containing drugs
    An FDA panel was set this week to consider reclassifying hydrocodone-containing products from Schedule III to Schedule II drugs. "Even if we change hydrocodone-containing products from Schedule III to Schedule II, it in no way jeopardizes access. What this means is that patients who might be able to go to their doctor every six months would now have to see their doctor every three months [to get a prescription]," said Dr. Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing. HealthDay News (1/24) LinkedInFacebookTwitterEmail this Story
  PBM Industry News 
  Drug Industry Spotlight 
  SmartQuote 
In youth we learn; in age we understand."
--Marie von Ebner-Eschenbach,
Austrian writer


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information